Imricor Medical Systems (IMR.AX) Stock Analysis & Winston Score

Imricor Medical Systems makes medical devices that allow doctors to perform heart procedures inside MRI machines. Normally, heart procedures called cardiac ablations are done using X-ray imaging, but Imricor's tools are designed to work safely inside MRI scanners instead. The company's main product is the Vision-MR Ablation System, which is sold to hospitals in Europe, where it has regulatory approval. Imricor earns revenue by selling its catheters and other single-use disposable tools to hospitals, along with the equipment needed to run the system. The company is small, with a market cap around $400 million, and is still in an early commercial stage, which explains its deeply negative margins. Its main competitive advantage is that it holds a unique position as one of the only companies with MRI-compatible cardiac ablation technology, but the biggest risk is that it must convince hospitals to adopt a new and unfamiliar workflow before it runs out of cash to fund operations.